Evaluating diagnostic and therapeutic strategies for thyroid conditions
Evaluation of Different Diagnostic Therapeutic Strategies in Patients with Thyroid Pathology
This study is testing different ways to diagnose and treat thyroid problems, like hypothyroidism and thyroid cancer, to see which methods work best for patients.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 5850 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna Academic / other |
| Locations | 1 site (Bologna, Bologna) |
| Trial ID | NCT06779747 on ClinicalTrials.gov |
What this trial studies
This observational study will assess different diagnostic and therapeutic strategies in patients with various thyroid pathologies, including hypothyroidism, hyperthyroidism, benign thyroid nodules, and thyroid carcinoma. It will involve both retrospective and prospective phases, enrolling patients diagnosed from 1995 onwards and following them for up to 20 years. The study will collect clinical data that is typically gathered in routine practice without any additional procedures beyond standard care.
Who should consider this trial
Good fit: Ideal candidates include adults over 18 years with diagnosed thyroid pathologies who can provide informed consent.
Not a fit: Patients with incomplete clinical data or those whose follow-up is less than 3 months may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the understanding and management of thyroid conditions, leading to better patient outcomes.
How similar studies have performed: While similar observational studies have been conducted, this specific approach focusing on a comprehensive evaluation of diagnostic strategies in thyroid pathology is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age older than 18 years at the time of diagnosis; * Patients with thyroid pathology (hypothyroidism, hyperthyroidism/thyrotoxicosis, benign thyroid nodule, and thyroid carcinoma) in whom the diagnosis was made in our Center or another Center from 01/01/1995 until the approval of this study (retrospective phase) or from the time of approval of this study to the next 10 years (prospective phase); * Obtaining informed consent. Exclusion Criteria: * Follow up lasting less than 3 months; * Incomplete or missing clinical data that may affect the correct assessment of the patient.
Where this trial is running
Bologna, Bologna
- IRCCS Azienda Ospedaliero-Universitaria di Bologna — Bologna, Bologna, Italy (Recruiting)
Study contacts
- Principal investigator: Uberto Pagotto, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Study coordinator: Uberto Pagotto, MD
- Email: uberto.pagotto@unibo.it
- Phone: +390512144190
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.